HIGHLIGHTS
- who: Report et al. from the Internal Medicine, Arrowhead Regional Medical Center, Colton, USA have published the research: Review began 12/22/2022 Review ended 01/04/2023 Published 01/06/2023 u00a9 Copyright, in the Journal: (JOURNAL) of January/06,/2023
- what: SMZL`s low incidence, indolent course, elusive diagnostic criteria, and limited evidence-based treatments represent a significant challenge for clinicians.
SUMMARY
Splenic marginal zone lymphoma (SMZL) is a low-grade, mature B-cell lymphoma that is categorized as non-Hodgkin lymphoma (NHL) and subclassified as a marginal zone . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.